| XLS |
EUR million |
1st quarter |
1st quarter |
Profit after tax |
194.6 |
60.2 |
Depreciation/amortization and impairment losses (non-current assets) |
246.4 |
223.4 |
Changes in inventories |
–20.6 |
–56.3 |
Changes in trade accounts receivable |
–197.3 |
–35.6 |
Changes in trade accounts payable |
–15.3 |
–31.0 |
Changes in provisions |
–28.9 |
92.9 |
Changes in other assets and liabilities |
103.5 |
25.2 |
Neutralization of gain/loss on disposals of assets |
–0.9 |
1.4 |
Other non-cash income and expenses |
–2.7 |
2.5 |
Net cash flows from operating activities |
278.7 |
282.7 |
|
|
|
Purchase of intangible assets |
–14.0 |
–27.0 |
Purchase of property, plant and equipment |
–64.7 |
–89.0 |
Acquisitions and investments of non-current financial assets |
–7.8 |
–8.3 |
Disposal of non-current assets |
3.9 |
3.9 |
Purchase/sale of marketable securities |
–1.3 |
1.8 |
Changes in financial assets covering pensions |
–1.9 |
–64.5 |
Changes in other financial assets |
1,355.4 |
–183,3 |
Net cash flows from investing activities |
1,269.5 |
–366.4 |
|
|
|
Dividends payments |
–2.5 |
–2.1 |
Profit transfers to E. Merck KG and changes in reserves |
–49.4 |
28.7 |
Changes in liabilities to E. Merck KG |
21.1 |
–42.0 |
Bonds issued |
3,181.7 |
746.0 |
Changes in current and non-current financial liabilities |
–15.7 |
0.3 |
Net cash flows from financing activities |
3,135.2 |
730.8 |
|
|
|
Changes in cash and cash equivalents |
4,683.4 |
647.0 |
Changes in cash and cash equivalents due to currency translation |
7.9 |
3.1 |
Cash and cash equivalents as of January 1 |
541.4 |
692.7 |
Cash and cash equivalents as of March 31 |
5,232.7 |
1,342.8 |